Among them, miR-4669 and miR-4537 were found to simultaneously target FCAR and SRC, while miR-3619-3P was predicted to regulate TLR8 and SRC. Although the roles of these miRNAs in AIS remain unclear, studies in other disease contexts provide preliminary insights. Here, TLR8 is linked to androgen insensitivity syndrome.